Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $375.4700 (1.49%) ($370.2000 - $381.3200) on Mon. May. 9, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.87% (three month average) | RSI | 35 | Latest Price | $375.4700(1.49%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.5% a day on average for past five trading days. | Weekly Trend | REGN declines -4.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(63%) XLV(51%) XBI(47%) IVW(41%) QQQ(41%) | Factors Impacting REGN price | REGN will decline at least -1.435% in a week (0% probabilities). VIXM(-11%) UUP(-8%) TLT(-8%) IPO(-5%) SHY(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.435% (StdDev 2.87%) | Hourly BBV | 0 () | Intraday Trend | 1.4% | | | |
|
Resistance Level | $393.72 | 5 Day Moving Average | $371.02(1.2%) | 10 Day Moving Average | $379.85(-1.15%) | 20 Day Moving Average | $393.72(-4.64%) | To recent high | -12.1% | To recent low | 4.4% | Market Cap | $39.811b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |